Genome editing in plants can deliver beneficial crop properties such as drought and pest resistance, but the resulting products are also feared by some to lead to health and biodiversity risks in the long term. On 29^th April 2021, the EU Commission published its long-awaited report on new genome editing techniques, hinting at deregulation of products resulting from genome editing amidst accusations of aggressive biotech industry lobbying. In this blogpost, Pauline Phoa discusses the legal background to the Commission’s report, as well as some concerns about the way forward.